Laurion Capital Management’s bluebird bio BLUE Stock Holding History

Laurion Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-507	Closed	-$42K	–	494
2022 Q2	$42K	Buy	+507	New	+$39.3K	﹤0.01%	437
2019 Q3	–	Sell	-1,187	Closed	-$1.96M	–	1021
2019 Q2	$1.96M	Buy	+1,187	New	+$2.05M	0.02%	384
2019 Q1	–	Sell	-1,060	Closed	-$1.36M	–	873
2018 Q4	$1.36M	Sell	1,060 -6,895	-87%	-$10.6M	0.02%	494
2018 Q3	$15M	Buy	+7,955	New	+$16.4M	0.15%	157
2018 Q1	–	Sell	-11,281	Closed	-$26M	–	1347
2017 Q4	$26M	Buy	+11,281	New	+$22.9M	0.13%	167
2017 Q3	–	Sell	-15,506	Closed	-$21.1M	–	1576
2017 Q2	$21.1M	Buy	+15,506	New	+$18.7M	0.12%	169
2017 Q1	–	Sell	-448	Closed	-$358K	–	1301
2016 Q4	$358K	Sell	448 -3,373	-88%	-$2.68M	﹤0.01%	898
2016 Q3	$3.35M	Buy	+3,821	New	+$2.77M	0.03%	389
2016 Q2	–	Sell	-2,409	Closed	-$1.33M	–	825
2016 Q1	$1.33M	Buy	+2,409	New	+$1.48M	0.02%	386

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Laurion Capital Management's BLUE Position: Q3 2022 in Review

Laurion Capital Management sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 507 shares — an estimated $42K sold.

Laurion Capital Management first reported a position in BLUE in Q1 2016 and held it in 9 quarters. The position peaked at $26M in Q4 2017. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.

Laurion Capital Management reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
Laurion Capital Management sold 507 bluebird bio shares in Q3 2022, an estimated $42K.
Laurion Capital Management first reported a position in bluebird bio in Q1 2016 and held it in 9 quarters.
Laurion Capital Management's bluebird bio position peaked at $26M in Q4 2017.
162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.